Kairos Pharma Ltd

Penny Stocks Biotech Stocks Healthcare Stocks

$1.68

-0.04 (-2.33%)

As of Sep 28, 10:40 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +378.6% upside

Low Target $5.03

Average Target $8.04

High Target $9.33

Current Price $1.68

Current
$1.68

Target
$8.04

$5.03 $8.04 avg $9.33

Scenario Analysis

Bear Case

$5.03

199.4%

Low target

Base Case

$8.04

+378.6%

Avg target

Bull Case

$9.33

+455.4%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$9.59

-82.5% from high

52-Week Low

$1.51

+11.3% from low

Target vs 52W High

$8.04

-16.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.3%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+138.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.4%